Skip to content
Recall Observatory FDA recall evidence

Drug product

VELCADE (bortezomib) for injection, 3.5 mg/vial, Reconstitution Information, SUBCUTANEOUS INJECTION ONLY add 1.4 mL 0.9% Sodium Chloride to make 2.5 mg/ mL final concentration, INTRAVENOUS INJECTION ONLY add 3.5 mL Sodium Chloride to 1 mg/mL final concentration, Rx Only, Distributed by MILLENNIUM Pharmaceuticals, Inc., Cambridge, MA 02139-4234, NDC 63020-0049-01

D-0425-2018

January 30, 2018

Class II

Product summary

Firm
Millennium Pharmaceuticals Inc.
Event
Event 79083
Status
Terminated
Classification
Class II
Quantity
154,372 vials
Official record key
drug-enforcement:D-0425-2018

Official wording

Reason: Defective Container: Confirmed reports of loose vial crimps.

Code information: Lot Numbers # 224161, 224546 and 224547; Exp. 12/19

Distribution pattern: Distributed nationwide. They estimate 4% of the product may be recovered.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Container: Confirmed reports of loose vial crimps.